Connection

TIMOTHY LOTZE to Humans

This is a "connection" page, showing publications TIMOTHY LOTZE has written about Humans.
Connection Strength

0.670
  1. Novel use of nusinersen as a therapeutic bridge to onasemnogene abeparvovec-xioi in a premature neonate with type 1 spinal muscular atrophy. Muscle Nerve. 2022 08; 66(2):E8-E10.
    View in: PubMed
    Score: 0.022
  2. Neurology in a Pandemic. Neurol Clin. 2021 08; 39(3):699-704.
    View in: PubMed
    Score: 0.021
  3. Novel Treatments and Clinical Research in Child Neurology. Neurol Clin. 2021 08; 39(3):719-722.
    View in: PubMed
    Score: 0.021
  4. Clinical exome sequencing in the diagnosis of pediatric neuromuscular disease. Muscle Nerve. 2021 03; 63(3):304-310.
    View in: PubMed
    Score: 0.020
  5. Headache and Hypoglossal Nerve Palsy in a Child With Idiopathic Hypertrophic Pachymeningitis. Headache. 2019 09; 59(8):1390-1391.
    View in: PubMed
    Score: 0.018
  6. Global Health Education in Child Neurology and Neurodevelopmental Disabilities Training Programs in the United States: A National Survey. J Child Neurol. 2019 07; 34(8):452-457.
    View in: PubMed
    Score: 0.018
  7. Health-Related Quality of Life in Pediatric Patients With Demyelinating Diseases: Relevance of Disability, Relapsing Presentation, and Fatigue. J Pediatr Psychol. 2018 03 01; 43(2):133-142.
    View in: PubMed
    Score: 0.017
  8. Therapeutic Plasma Exchange Use in Pediatric Neurologic Disorders at a Tertiary Care Center: A 10-Year Review. J Child Neurol. 2018 02; 33(2):140-145.
    View in: PubMed
    Score: 0.016
  9. Utility of whole exome sequencing in evaluation of juvenile motor neuron disease. Muscle Nerve. 2016 Apr; 53(4):648-52.
    View in: PubMed
    Score: 0.014
  10. Lymphocytic hypophysitis associated with pediatric multiple sclerosis. Pediatr Neurol. 2014 Oct; 51(4):580-2.
    View in: PubMed
    Score: 0.013
  11. Child Neurology: a case of PMM2-CDG (CDG 1a) presenting with unusual eye movements. Neurology. 2012 Oct 09; 79(15):e131-3.
    View in: PubMed
    Score: 0.011
  12. Pediatric acute transverse myelitis overview and differential diagnosis. J Child Neurol. 2012 Nov; 27(11):1426-36.
    View in: PubMed
    Score: 0.011
  13. Intracranial optic nerve enlargement in infantile Krabbe disease. Neurology. 2012 May 15; 78(20):e126.
    View in: PubMed
    Score: 0.011
  14. Spectrum of pediatric neuromyelitis optica. Pediatrics. 2008 Nov; 122(5):e1039-47.
    View in: PubMed
    Score: 0.009
  15. Case report: "Purely" psychiatric presentation of multiple sclerosis in an adolescent boy. J Am Acad Child Adolesc Psychiatry. 2007 Sep; 46(9):1213-1217.
    View in: PubMed
    Score: 0.008
  16. Association Between Sun Exposure and Risk of Relapse in Pediatric-Onset Multiple Sclerosis. Neurol Neuroimmunol Neuroinflamm. 2025 Mar; 12(2):e200375.
    View in: PubMed
    Score: 0.007
  17. Study of the Association Between Menarche and Disease Course in Pediatric Multiple Sclerosis. Neurology. 2025 Feb 25; 104(4):e210213.
    View in: PubMed
    Score: 0.007
  18. Distinct plasma lipids predict axonal injury and multiple sclerosis activity. J Neurol Neurosurg Psychiatry. 2025 Jan 16; 96(2):150-157.
    View in: PubMed
    Score: 0.007
  19. Frequency and nature of cerebellar injury in the extremely premature survivor with cerebral palsy. J Child Neurol. 2005 Jan; 20(1):60-4.
    View in: PubMed
    Score: 0.007
  20. Predictors of a relapsing course in myelin oligodendrocyte glycoprotein antibody-associated disease. J Neurol Neurosurg Psychiatry. 2024 Dec 16; 96(1):68-75.
    View in: PubMed
    Score: 0.007
  21. Epidemiology and Impact of Social Hardships in Children With Multiple Sclerosis in the United States. Neurology. 2024 Dec 10; 103(11):e209991.
    View in: PubMed
    Score: 0.007
  22. Biallelic variation in the choline and ethanolamine transporter FLVCR1 underlies a severe developmental disorder spectrum. Genet Med. 2025 Jan; 27(1):101273.
    View in: PubMed
    Score: 0.007
  23. Patient and family views on research priorities and design of clinical trials and research studies in pediatric multiple sclerosis. Mult Scler. 2024 Oct; 30(11-12):1525-1543.
    View in: PubMed
    Score: 0.007
  24. Early Adversity and Socioeconomic Factors in Pediatric Multiple Sclerosis: A Case-Control Study. Neurol Neuroimmunol Neuroinflamm. 2024 Sep; 11(5):e200282.
    View in: PubMed
    Score: 0.006
  25. Association of nutritional intake with clinical and imaging activity in pediatric multiple sclerosis. Mult Scler. 2024 Jul; 30(8):1056-1065.
    View in: PubMed
    Score: 0.006
  26. Clinical and magnetic resonance imaging outcomes in pediatric-onset MS patients on fingolimod and ocrelizumab. Mult Scler Relat Disord. 2024 Jul; 87:105647.
    View in: PubMed
    Score: 0.006
  27. Gene-environment interactions: Epstein-Barr virus infection and risk of pediatric-onset multiple sclerosis. Mult Scler. 2024 Mar; 30(3):308-315.
    View in: PubMed
    Score: 0.006
  28. Zonisamide treatment for symptomatic infantile spasms. Neurology. 2004 Jan 27; 62(2):296-8.
    View in: PubMed
    Score: 0.006
  29. Anterior cervical discectomy and fusion for the treatment of pediatric Hirayama disease. Childs Nerv Syst. 2024 May; 40(5):1427-1434.
    View in: PubMed
    Score: 0.006
  30. Gene-environment interactions and risk of pediatric-onset multiple sclerosis associated with time spent outdoors. Mult Scler Relat Disord. 2024 Feb; 82:105351.
    View in: PubMed
    Score: 0.006
  31. Assessing Needs and Perceptions of Research Participation in Pediatric-Onset Multiple Sclerosis: A Multistakeholder Survey. Pediatr Neurol. 2024 Feb; 151:115-120.
    View in: PubMed
    Score: 0.006
  32. Novel Genetic and Phenotypic Expansion in GOSR2-Related Progressive Myoclonus Epilepsy. Genes (Basel). 2023 09 25; 14(10).
    View in: PubMed
    Score: 0.006
  33. Cation leak through the ATP1A3 pump causes spasticity and intellectual disability. Brain. 2023 08 01; 146(8):3162-3171.
    View in: PubMed
    Score: 0.006
  34. Fulminant Anti-Myelin Oligodendrocyte Glycoprotein-Associated Cerebral Cortical Encephalitis: Case Series of a Severe Pediatric Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease Phenotype. Pediatr Neurol. 2023 10; 147:36-43.
    View in: PubMed
    Score: 0.006
  35. An International Pediatric-Onset Opsoclonus-Myoclonus Ataxia Syndrome Registry and Clinical Research Network: Development, Progress, and Vision. Pediatr Neurol. 2023 11; 148:145-147.
    View in: PubMed
    Score: 0.006
  36. Bi-allelic variants in HMGCR cause an autosomal-recessive progressive limb-girdle muscular dystrophy. Am J Hum Genet. 2023 06 01; 110(6):989-997.
    View in: PubMed
    Score: 0.006
  37. Demographic Features and Clinical Course of Patients With Pediatric-Onset Multiple Sclerosis on Newer Disease-Modifying Treatments. Pediatr Neurol. 2023 Aug; 145:125-131.
    View in: PubMed
    Score: 0.006
  38. Characteristics of pediatric patients with multiple sclerosis and related disorders infected with SARS-CoV-2. Mult Scler. 2023 04; 29(4-5):576-584.
    View in: PubMed
    Score: 0.006
  39. Paroxysmal kinesigenic dyskinesias. Semin Pediatr Neurol. 2003 Mar; 10(1):68-79.
    View in: PubMed
    Score: 0.006
  40. Silent findings: Examination of asymptomatic demyelination in a pediatric US cohort. Mult Scler Relat Disord. 2023 Mar; 71:104573.
    View in: PubMed
    Score: 0.006
  41. Gene-environment interactions increase the risk of paediatric-onset multiple sclerosis associated with household chemical exposures. J Neurol Neurosurg Psychiatry. 2023 07; 94(7):518-525.
    View in: PubMed
    Score: 0.006
  42. Therapeutic Response in Pediatric Neuromyelitis Optica Spectrum Disorder. Neurology. 2023 02 28; 100(9):e985-e994.
    View in: PubMed
    Score: 0.006
  43. Bethlem Myopathy (Collagen VI-Related Dystrophies): A Retrospective Cohort Study on Musculoskeletal Pathologies and Clinical Course. J Pediatr Orthop. 2023 Feb 01; 43(2):e163-e167.
    View in: PubMed
    Score: 0.006
  44. MOG and AQP4 Antibodies among Children with Multiple Sclerosis and Controls. Ann Neurol. 2023 02; 93(2):271-284.
    View in: PubMed
    Score: 0.006
  45. A new look at cognitive functioning in pediatric MS. Mult Scler. 2023 01; 29(1):140-149.
    View in: PubMed
    Score: 0.006
  46. Management of Extensive Central Nervous System Cladophialophora bantiana Infection in a 9-Year-Old Child. Pediatr Infect Dis J. 2022 11 01; 41(11):e481-e486.
    View in: PubMed
    Score: 0.006
  47. TLR7 gain-of-function genetic variation causes human lupus. Nature. 2022 05; 605(7909):349-356.
    View in: PubMed
    Score: 0.006
  48. Diagnosis and Management of Opsoclonus-Myoclonus-Ataxia Syndrome in Children: An International Perspective. Neurol Neuroimmunol Neuroinflamm. 2022 05; 9(3).
    View in: PubMed
    Score: 0.005
  49. Gene-environment interactions increase the risk of pediatric-onset multiple sclerosis associated with ozone pollution. Mult Scler. 2022 08; 28(9):1330-1339.
    View in: PubMed
    Score: 0.005
  50. Deep clinicopathological phenotyping identifies a previously unrecognized pathogenic EMD splice variant. Ann Clin Transl Neurol. 2021 10; 8(10):2052-2058.
    View in: PubMed
    Score: 0.005
  51. Double Vision and Gait Ataxia in an Immunocompetent 9-Year-Old Girl With Intracranial Phaeohyphomycosis. J Neuroophthalmol. 2021 09 01; 41(3):399-403.
    View in: PubMed
    Score: 0.005
  52. Familial History of Autoimmune Disorders Among Patients With Pediatric Multiple Sclerosis. Neurol Neuroimmunol Neuroinflamm. 2021 09; 8(5).
    View in: PubMed
    Score: 0.005
  53. Inflammatory Diseases of the Central Nervous System. Neurol Clin. 2021 08; 39(3):811-828.
    View in: PubMed
    Score: 0.005
  54. A novel de novo intronic variant in ITPR1 causes Gillespie syndrome. Am J Med Genet A. 2021 08; 185(8):2315-2324.
    View in: PubMed
    Score: 0.005
  55. Rare deleterious mutations of HNRNP genes result in shared neurodevelopmental disorders. Genome Med. 2021 04 19; 13(1):63.
    View in: PubMed
    Score: 0.005
  56. Pediatric Autoimmune Ocular Myasthenia Gravis: Evaluation of Presentation and Treatment Outcomes in a Large Cohort. Pediatr Neurol. 2021 05; 118:12-19.
    View in: PubMed
    Score: 0.005
  57. Association of Rituximab Use With Adverse Events in Children, Adolescents, and Young Adults. JAMA Netw Open. 2021 02 01; 4(2):e2036321.
    View in: PubMed
    Score: 0.005
  58. A novel ATP1A2 variant associated with severe stepwise regression, hemiplegia, epilepsy and movement disorders in two unrelated patients. Eur J Paediatr Neurol. 2021 Mar; 31:21-26.
    View in: PubMed
    Score: 0.005
  59. Developing a New Set of ACGME Milestones for Child Neurology Residency. Pediatr Neurol. 2021 01; 114:47-52.
    View in: PubMed
    Score: 0.005
  60. Vertebral artery dissection and migraine headaches in children. J Child Neurol. 2000 Oct; 15(10):694-6.
    View in: PubMed
    Score: 0.005
  61. Improved relapse recovery in paediatric compared to adult multiple sclerosis. Brain. 2020 09 01; 143(9):2733-2741.
    View in: PubMed
    Score: 0.005
  62. Pediatric Multiple Sclerosis Severity Score in a large US cohort. Neurology. 2020 09 29; 95(13):e1844-e1853.
    View in: PubMed
    Score: 0.005
  63. Real-World Effectiveness of Initial Disease-Modifying Therapies in Pediatric Multiple Sclerosis. Ann Neurol. 2020 07; 88(1):42-55.
    View in: PubMed
    Score: 0.005
  64. Infectious and Autoimmune Causes of Encephalitis in Children. Pediatrics. 2020 06; 145(6).
    View in: PubMed
    Score: 0.005
  65. GARS-related disease in infantile spinal muscular atrophy: Implications for diagnosis and treatment. Am J Med Genet A. 2020 05; 182(5):1167-1176.
    View in: PubMed
    Score: 0.005
  66. Cognitive processing speed in pediatric-onset multiple sclerosis: Baseline characteristics of impairment and prediction of decline. Mult Scler. 2020 12; 26(14):1938-1947.
    View in: PubMed
    Score: 0.005
  67. miRNA contributions to pediatric-onset multiple sclerosis inferred from GWAS. Ann Clin Transl Neurol. 2019 Jun; 6(6):1053-1061.
    View in: PubMed
    Score: 0.004
  68. Vitamin D genes influence MS relapses in children. Mult Scler. 2020 07; 26(8):894-901.
    View in: PubMed
    Score: 0.004
  69. Admixture mapping reveals evidence of differential multiple sclerosis risk by genetic ancestry. PLoS Genet. 2019 01; 15(1):e1007808.
    View in: PubMed
    Score: 0.004
  70. Acquisition of Early Developmental Milestones and Need for Special Education Services in Pediatric Multiple Sclerosis. J Child Neurol. 2019 03; 34(3):148-152.
    View in: PubMed
    Score: 0.004
  71. Use of newer disease-modifying therapies in pediatric multiple sclerosis in the US. Neurology. 2018 11 06; 91(19):e1778-e1787.
    View in: PubMed
    Score: 0.004
  72. Identifying Opportunities to Provide Family-centered Care for Families With Children With Type 1 Spinal Muscular Atrophy. J Pediatr Nurs. 2018 Nov - Dec; 43:111-119.
    View in: PubMed
    Score: 0.004
  73. Ultrasound-guided cervical puncture for nusinersen administration in adolescents. Pediatr Radiol. 2019 01; 49(1):136-140.
    View in: PubMed
    Score: 0.004
  74. Early infectious exposures are not associated with increased risk of pediatric-onset multiple sclerosis. Mult Scler Relat Disord. 2018 May; 22:103-107.
    View in: PubMed
    Score: 0.004
  75. Contribution of dietary intake to relapse rate in early paediatric multiple sclerosis. J Neurol Neurosurg Psychiatry. 2018 01; 89(1):28-33.
    View in: PubMed
    Score: 0.004
  76. Genetic risk factors for pediatric-onset multiple sclerosis. Mult Scler. 2018 12; 24(14):1825-1834.
    View in: PubMed
    Score: 0.004
  77. Examining the contributions of environmental quality to pediatric multiple sclerosis. Mult Scler Relat Disord. 2017 Nov; 18:164-169.
    View in: PubMed
    Score: 0.004
  78. Clinically severe CACNA1A alleles affect synaptic function and neurodegeneration differentially. PLoS Genet. 2017 Jul; 13(7):e1006905.
    View in: PubMed
    Score: 0.004
  79. The Experience of Families With Children With Spinal Muscular Atrophy Type I Across Health Care Systems. J Child Neurol. 2017 Oct; 32(11):917-923.
    View in: PubMed
    Score: 0.004
  80. Dietary factors and pediatric multiple sclerosis: A case-control study. Mult Scler. 2018 07; 24(8):1067-1076.
    View in: PubMed
    Score: 0.004
  81. Lung Transplantation for FLNA-Associated Progressive Lung Disease. J Pediatr. 2017 07; 186:118-123.e6.
    View in: PubMed
    Score: 0.004
  82. Impact of an electronic monitoring device and behavioral feedback on adherence to multiple sclerosis therapies in youth: results of a randomized trial. Qual Life Res. 2017 09; 26(9):2333-2349.
    View in: PubMed
    Score: 0.004
  83. Evidence for a causal relationship between low vitamin D, high BMI, and pediatric-onset MS. Neurology. 2017 Apr 25; 88(17):1623-1629.
    View in: PubMed
    Score: 0.004
  84. Evaluating the association of allergies with multiple sclerosis susceptibility risk and disease activity in a pediatric population. J Neurol Sci. 2017 Apr 15; 375:371-375.
    View in: PubMed
    Score: 0.004
  85. Recurrent De Novo and Biallelic Variation of ATAD3A, Encoding a Mitochondrial Membrane Protein, Results in Distinct Neurological Syndromes. Am J Hum Genet. 2016 Oct 06; 99(4):831-845.
    View in: PubMed
    Score: 0.004
  86. Pediatric transverse myelitis. Neurology. 2016 Aug 30; 87(9 Suppl 2):S46-52.
    View in: PubMed
    Score: 0.004
  87. Characteristics of Children and Adolescents With Multiple Sclerosis. Pediatrics. 2016 07; 138(1).
    View in: PubMed
    Score: 0.004
  88. A case-control study of dietary salt intake in pediatric-onset multiple sclerosis. Mult Scler Relat Disord. 2016 Mar; 6:87-92.
    View in: PubMed
    Score: 0.004
  89. Relation of Cardiac Dysfunction to Rhythm Abnormalities in Patients With Duchenne or Becker Muscular Dystrophies. Am J Cardiol. 2016 Apr 15; 117(8):1349-54.
    View in: PubMed
    Score: 0.004
  90. Recurrent Muscle Weakness with Rhabdomyolysis, Metabolic Crises, and Cardiac Arrhythmia Due to Bi-allelic TANGO2 Mutations. Am J Hum Genet. 2016 Feb 04; 98(2):347-57.
    View in: PubMed
    Score: 0.004
  91. Clinical features of neuromyelitis optica in children: US Network of Pediatric MS Centers report. Neurology. 2016 Jan 19; 86(3):245-52.
    View in: PubMed
    Score: 0.004
  92. Methionyl-tRNA Formyltransferase (MTFMT) Deficiency Mimicking Acquired Demyelinating Disease. J Child Neurol. 2016 Feb; 31(2):215-9.
    View in: PubMed
    Score: 0.003
  93. Feasibility and Reproducibility of Echocardiographic Measures in Children with Muscular Dystrophies. J Am Soc Echocardiogr. 2015 Aug; 28(8):999-1008.
    View in: PubMed
    Score: 0.003
  94. Protective environmental factors for neuromyelitis optica. Neurology. 2014 Nov 18; 83(21):1923-9.
    View in: PubMed
    Score: 0.003
  95. Mutations in PURA cause profound neonatal hypotonia, seizures, and encephalopathy in 5q31.3 microdeletion syndrome. Am J Hum Genet. 2014 Nov 06; 95(5):579-83.
    View in: PubMed
    Score: 0.003
  96. The US Network of Pediatric Multiple Sclerosis Centers: Development, Progress, and Next Steps. J Child Neurol. 2015 Sep; 30(10):1381-7.
    View in: PubMed
    Score: 0.003
  97. A 7-year-old child with chronic droopy eyes, weakness in head-neck control, and an abnormal gait. Semin Pediatr Neurol. 2014 Jun; 21(2):111-3.
    View in: PubMed
    Score: 0.003
  98. Mutations in VRK1 associated with complex motor and sensory axonal neuropathy plus microcephaly. JAMA Neurol. 2013 Dec; 70(12):1491-8.
    View in: PubMed
    Score: 0.003
  99. Novel cardiovascular findings in association with a POMT2 mutation: three siblings with a-dystroglycanopathy. Eur J Hum Genet. 2014 Apr; 22(4):486-91.
    View in: PubMed
    Score: 0.003
  100. A child with an inherited 0.31?Mb microdeletion of chromosome 14q32.33: further delineation of a critical region for the 14q32 deletion syndrome. Am J Med Genet A. 2012 Aug; 158A(8):1962-6.
    View in: PubMed
    Score: 0.003
  101. Randomized, blinded trial of weekend vs daily prednisone in Duchenne muscular dystrophy. Neurology. 2011 Aug 02; 77(5):444-52.
    View in: PubMed
    Score: 0.003
  102. Atypical presentation of Leigh syndrome associated with a Leber hereditary optic neuropathy primary mitochondrial DNA mutation. Mol Genet Metab. 2011 Jun; 103(2):153-60.
    View in: PubMed
    Score: 0.003
  103. Recurrent reciprocal 1q21.1 deletions and duplications associated with microcephaly or macrocephaly and developmental and behavioral abnormalities. Nat Genet. 2008 Dec; 40(12):1466-71.
    View in: PubMed
    Score: 0.002
  104. Role of MRI in the differentiation of ADEM from MS in children. Neurology. 2009 Mar 17; 72(11):968-73.
    View in: PubMed
    Score: 0.002
  105. MRI in the diagnosis of pediatric multiple sclerosis. Neurology. 2009 Mar 17; 72(11):961-7.
    View in: PubMed
    Score: 0.002
  106. Expanded clinical and molecular spectrum of guanidinoacetate methyltransferase (GAMT) deficiency. Mol Genet Metab. 2009 Jan; 96(1):38-43.
    View in: PubMed
    Score: 0.002
  107. CNS aquaporin-4 autoimmunity in children. Neurology. 2008 Jul 08; 71(2):93-100.
    View in: PubMed
    Score: 0.002
  108. Isolated mitochondrial myopathy associated with muscle coenzyme Q10 deficiency. Arch Neurol. 2005 Feb; 62(2):317-20.
    View in: PubMed
    Score: 0.002
  109. Neurologic complications associated with influenza A in children during the 2003-2004 influenza season in Houston, Texas. Pediatrics. 2004 Nov; 114(5):e626-33.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.